Precision Oncology Initiative

A gathering of hem/onc pharmacists for the 1-Day QTP session in Washington D.C., 2025
Spacer Image

Forming the Future of Cancer Care

Thanks to recent medical advances, precision oncology has developed into the fast-approaching future of optimized cancer care - and HOPA wants to ensure oncology pharmacists and their expertise are there for patients in that future.

To do so, HOPA introduces the Precision Oncology Initiative, a multi-year and multi-phase collaborative effort to advance the integration of oncology pharmacists into precision medicine, driving innovation, improving the quality of cancer care, and delivering long-term value across the healthcare system.

The Precision Oncology Initiative features five key phases:

Stakeholder Interviews

HOPA engaged diverse stakeholders – including pharmacists from academic and community practice settings, clinicians, organizational partners, and industry representatives – to identify trends, challenges, and opportunities in implementing precision oncology practices. The interviews revealed consistent themes across education, infrastructure, practice models, and collaboration.

Lessons learned from these interviews are shaping HOPA's upcoming educational programming and Precision Oncology Summit.

Educational Programming

To support the evolving needs of the oncology workforce, HOPA is launching an educational program designed to build foundational knowledge in precision oncology for oncology pharmacists at all career stages.

Coming soon

  • Testing Comparison Chart – A practical, quick-reference guide to help pharmacists identify which biomarkers are assessed by various testing companies
  • Precision Oncology Practice Roundtable – Featuring brief 10-minute recorded presentations from oncology pharmacists across academic medical centers, community practices, government/VA systems, and consultant roles. Followed by a 30-minute moderated discussion exploring these diverse practice models and practical implementation strategies

HOPA/ASCO 6-Month QTP

In collaboration with ASCO's Quality Training Program (QTP), HOPA will support 10 multidisciplinary, pharmacist-led teams from cancer care sites across the country in completing quality improvement (QI) projects all focused on precision medicine in oncology. Each team is paired with an ASCO QTP coach and guided through every stage of the QI process - from project design to implementation and evaluation.

Meet our teams:

  • Advocate Aurora Health – Milwaukee, WI
  • Atrium Health Wake Forest Baptist – Winston Salem, NC
  • Avera Cancer Institute – Sioux Falls, SD
  • Froedtert & the Medical College of Wisconsin – Milwaukee, WI
  • Hollings Cancer Center (MUSC) – Charleston, SC
  • Ivinson Memorial Hospital – Laramie, WY
  • St. Luke's Cancer Institute – Boise, ID
  • Stanford Health Care – Palo Alto, CA
  • University of Virginia Health – Charlottesville, VA
  • Wentworth-Douglas Hospital – Dover, NH

Throughout the initiative, teams will share progress updates, including key learnings, successes, and challenges – creating opportunities for shared insights and identifying scalable best practices.

Precision Oncology Summit

In fall 2026, HOPA is hosting a summit with oncology pharmacists, industry partners, collaborative organizations, and healthcare decision-makers to address key barriers to precision oncology implementation and access – through the lens of the oncology pharmacist.

This full-day, action-oriented summit is designed to move beyond discussion and into execution, featuring roundtable discussions with report outs to foster collaboration, alignment, and shared learning. These conversations will shape HOPA's strategy to close identified gaps and guide the development of real-world tools and resources for clinical practice.

Professional Tools and Resources

Building on insights from earlier phases, HOPA will collaborate with strategic partners to develop practical tools and resources that support the integration of precision oncology into pharmacists' daily practice.

HOPA will develop materials such as guidance documents, decision-support tools, and educational content aimed at improving treatment selection, care coordination, and patient outcomes. These resources will be designed for broad adoption across the healthcare team, helping to standardize and scale precision oncology practices nationwide.

Sponsors

Precision Oncology Initiative sponsors

Precision Oncology Initiative sponsors 2

If you are interested in partnering on this initiative or would like to learn more, please contact HOPA Director of Strategic Partnership Nicole Watts at nwatts@hoparx.org.